×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Microbot Medical Stock Forecast, Price & News

$5.01
-0.12 (-2.34%)
(As of 07/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$4.83
$5.15
50-Day Range
$4.71
$6.17
52-Week Range
$4.31
$9.60
Volume
5,499 shs
Average Volume
84,192 shs
Market Capitalization
$35.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Microbot Medical Stock Forecast (MarketRank)

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.73% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.85) to ($1.53) Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.86 out of 5 stars

Medical Sector

1185th out of 1,429 stocks

Biological Products, Except Diagnostic Industry

184th out of 217 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive MBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter.

Microbot Medical logo

About Microbot Medical (NASDAQ:MBOT)

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

MBOT Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MBOT
Employees
14
Year Founded
2010

Company Calendar

Last Earnings
11/15/2021
Today
7/02/2022
Next Earnings (Estimated)
8/15/2022
Fiscal Year End
12/31/2022

Profitability

Net Income
$-11.31 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.02 per share

Miscellaneous

Free Float
6,343,000
Market Cap
$35.61 million
Optionable
Not Optionable
Beta
3.99

Social Links















Microbot Medical Frequently Asked Questions

How has Microbot Medical's stock performed in 2022?

Microbot Medical's stock was trading at $7.50 at the beginning of the year. Since then, MBOT shares have decreased by 33.2% and is now trading at $5.01.
View the best growth stocks for 2022 here
.

When is Microbot Medical's next earnings date?

Microbot Medical is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022.
View our earnings forecast for Microbot Medical
.

How were Microbot Medical's earnings last quarter?

Microbot Medical Inc. (NASDAQ:MBOT) released its earnings results on Monday, November, 15th. The biotechnology company reported ($0.36) EPS for the quarter, meeting the consensus estimate of ($0.36).
View Microbot Medical's earnings history
.

When did Microbot Medical's stock split? How did Microbot Medical's stock split work?

Microbot Medical shares reverse split before market open on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split.

Who are Microbot Medical's key executives?

Microbot Medical's management team includes the following people:
  • Mr. Harel Gadot, Co-Founder, Pres, CEO & Chairman (Age 49, Pay $813.8k)
  • Mr. Yoseph Bornstein, CO-Founder & Independent Director (Age 63, Pay $52.5k)
  • Dr. Simon Sharon MBA, MSc, CTO & GM (Age 62, Pay $501.87k)
  • Dr. Eyal Morag M.D., Chief Medical Officer & Member of Scientific Advisory Board (Age 57, Pay $567.06k)
  • Prof. Moshe Shoham D.Sc., Co-Founder, Scientific Director & Chairman of Scientific Advisory Board (Age 70)
  • Ms. Rachel Vaknin, Chief Financial Officer

What other stocks do shareholders of Microbot Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include TransEnterix (TRXC), Advanced Micro Devices (AMD), Athersys (ATHX), NVIDIA (NVDA), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Novavax (NVAX), Pfizer (PFE), Micron Technology (MU) and Sorrento Therapeutics (SRNE).

What is Microbot Medical's stock symbol?

Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT."

How do I buy shares of Microbot Medical?

Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Microbot Medical's stock price today?

One share of MBOT stock can currently be purchased for approximately $5.01.

How much money does Microbot Medical make?

Microbot Medical (NASDAQ:MBOT) has a market capitalization of $35.61 million. The biotechnology company earns $-11.31 million in net income (profit) each year or ($1.420010) on an earnings per share basis.

How many employees does Microbot Medical have?

Microbot Medical employs 14 workers across the globe.

When was Microbot Medical founded?

Microbot Medical was founded in 2010.

How can I contact Microbot Medical?

Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The official website for Microbot Medical is www.microbotmedical.com. The biotechnology company can be reached via phone at (781) 875-3605, via email at [email protected], or via fax at 781-556-5347.

This page (NASDAQ:MBOT) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.